Inogen, Inc. (INGN)

$24.5

+0.32 (+1.32%)
Rating:
Recommendation:
Buy
Symbol INGN
Price $24.5
Beta 1.004
Volume Avg. 0.19M
Market Cap 559.477M
Shares () -
52 Week Range 22.51-82.35
1y Target Est -
DCF Unlevered INGN DCF ->
DCF Levered INGN LDCF ->
ROE -5.32% Neutral
ROA -4.17% Neutral
Operating Margin -
Debt / Equity 32.47% Neutral
P/E -
P/B 1.56 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest INGN news


Mr. Scott Wilkinson
Healthcare
Medical Devices
NASDAQ Global Select

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.